Stocks and Investing
Stocks and Investing
Thu, May 13, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Arlinda Lee Maintained (BNTX) at Strong Buy with Increased Target to $240 on, May 13th, 2021
Arlinda Lee of Canaccord Genuity, Maintained "BioNTech SE" (BNTX) at Strong Buy with Increased Target from $130 to $240 on, May 13th, 2021.
Arlinda has made no other calls on BNTX in the last 4 months.
There are 2 other peers that have a rating on BNTX. Out of the 2 peers that are also analyzing BNTX, all agree with Arlinda's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Daina Graybosch of "SVB Leerink" Maintained at Hold with Increased Target to $159 on, Tuesday, May 11th, 2021
- Olga Smolentseva of "Bryan Garnier" Downgraded from Strong Buy to Hold and Increased Target to $206 on, Tuesday, May 11th, 2021
Contributing Sources